MD Anderson
Nucleix, MD Anderson Partner on Methylation-Based Lung Cancer Dx Tests
The collaborators will initially evaluate methylation markers that they believe are important for characterizing lung cancer subtypes.
Early-Stage Lung Cancer Development Traced in Single-Cell RNA Sequencing Study
Researchers mapped the changes normal cells in the lung undergo as they evolve into cancerous cells and identified new targets for treatment.
MD Anderson, Orionis Biosciences Ink Partnership to Advance, Repurpose Small-Molecule Cancer Drugs
The research collaboration, dubbed Project Helios, will involve genome-scale mapping of drug-target interactions across the human proteome.
The transcription-based subtypes could differentiate which SCLC patients respond to treatments, such as immune checkpoint inhibitors and PARP inhibitors.
Metastatic Gastric Cancer Outcomes Informed by Single-Cell Transcriptome Profiles
Researchers used single-cell RNA sequencing to delve into intra-tumoral heterogeneity in peritoneal carcinomatosis, identifying a potential prognostic signature.
Nov 11, 2020
Oct 12, 2020
Feb 6, 2020
Dec 12, 2019
Proteomic Subtypes Identified in Pan-Cancer Analysis
Oct 31, 2019